[go: up one dir, main page]

DK309285D0 - PROCEDURE FOR DETERMINING SERUM IMMUNIC COMPLEXS - Google Patents

PROCEDURE FOR DETERMINING SERUM IMMUNIC COMPLEXS

Info

Publication number
DK309285D0
DK309285D0 DK309285A DK309285A DK309285D0 DK 309285 D0 DK309285 D0 DK 309285D0 DK 309285 A DK309285 A DK 309285A DK 309285 A DK309285 A DK 309285A DK 309285 D0 DK309285 D0 DK 309285D0
Authority
DK
Denmark
Prior art keywords
immunic
complexs
procedure
serum
determining serum
Prior art date
Application number
DK309285A
Other languages
Danish (da)
Other versions
DK309285A (en
Inventor
Rudolph P Reckel
Joanne L Harris
Ralph Wellerson Jr
Sally M Shaw
Paul M Kaplan
Original Assignee
Ortho Diagnostic Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Diagnostic Systems Inc filed Critical Ortho Diagnostic Systems Inc
Publication of DK309285D0 publication Critical patent/DK309285D0/en
Publication of DK309285A publication Critical patent/DK309285A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809—Multifield plates or multicontainer arrays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Method and test kit for detecting Clq-containing complexes in human serum containing native serum Cl. The method uses a monoclonal antibody which selectively reacts with human Clq in the presence of native human serum Cl. Preparation of hybridomas generating such antibodies is also disclosed. The method is applicable to detection of autoimmune diseases and AIDS.
DK309285A 1983-11-07 1985-07-05 PROCEDURE FOR DETERMINING SERUM IMMUNIC COMPLEXS DK309285A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/549,105 US4595654A (en) 1983-11-07 1983-11-07 Method for detecting immune complexes in serum
PCT/US1984/001803 WO1985002261A1 (en) 1983-11-07 1984-11-06 Method for detecting immune complexes in serum

Publications (2)

Publication Number Publication Date
DK309285D0 true DK309285D0 (en) 1985-07-05
DK309285A DK309285A (en) 1985-07-05

Family

ID=24191686

Family Applications (1)

Application Number Title Priority Date Filing Date
DK309285A DK309285A (en) 1983-11-07 1985-07-05 PROCEDURE FOR DETERMINING SERUM IMMUNIC COMPLEXS

Country Status (12)

Country Link
US (1) US4595654A (en)
EP (1) EP0161306B1 (en)
JP (2) JPH0731195B2 (en)
AT (1) ATE66531T1 (en)
AU (1) AU575362B2 (en)
CA (1) CA1247539A (en)
DE (1) DE3484957D1 (en)
DK (1) DK309285A (en)
IL (1) IL73437A (en)
IT (1) IT1177121B (en)
NO (1) NO852705L (en)
WO (1) WO1985002261A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595654A (en) * 1983-11-07 1986-06-17 Immunomedics Inc. Method for detecting immune complexes in serum
US5035995A (en) * 1984-10-02 1991-07-30 Calpis Food Industry Co., Ltd. Test method involving substance-conjugated complement component C1q
US4882423A (en) * 1984-10-02 1989-11-21 Calpis Food Industry Substance-conjugated complement component C1q
US4849352A (en) * 1984-10-09 1989-07-18 Sullivan John B Antibody purification process
US4753873A (en) * 1986-02-03 1988-06-28 Cambridge Bioscience Corporation Peptides for the diagnosis of HTLV-III antibodies, their preparation and use
AU6498494A (en) * 1993-04-08 1994-11-08 Board Of Regents, The University Of Texas System Model for gonococcal infection
US5691447A (en) * 1995-03-24 1997-11-25 Tanox Biosystems, Inc. GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
US5846758A (en) * 1995-11-30 1998-12-08 His Excellency Ghassan I. Shaker Method for diagnosing autoimmune diseases
WO1999059633A1 (en) 1998-05-20 1999-11-25 Immunomedics, Inc. Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
US20050054118A1 (en) * 2002-02-27 2005-03-10 Lebrun Stewart J. High throughput screening method
EP1520037A4 (en) * 2002-02-27 2006-06-07 Miragene Inc Improved substrate chemistry for protein immobilization on a rigid support
CA2532038C (en) * 2003-07-11 2013-11-26 Tatiana A. Egorova-Zachernyuk Compositions and methods for stable isotope labelling of biological compounds
US7923010B2 (en) * 2003-09-11 2011-04-12 The Board Of Regents Of The University Of Texas System Methods and materials for treating autoimmune diseases and conditions
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
WO2008035527A1 (en) * 2006-09-21 2008-03-27 Mmt Co., Ltd. ANTI-C1q MONOCLONAL ANTIBODY
ES2822058T3 (en) 2006-09-26 2021-04-28 Infectious Disease Res Inst Vaccine composition containing a synthetic adjuvant
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
PT2437753T (en) * 2009-06-05 2016-11-23 Infectious Disease Res Inst Synthetic glucopyranosyl lipid adjuvants and vaccine compositions containing them
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
CA2832307A1 (en) 2011-04-08 2012-10-18 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
PT2811981T (en) 2012-02-07 2019-06-12 Infectious Disease Res Inst Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
DK2850431T3 (en) 2012-05-16 2018-07-16 Immune Design Corp Vaccines against HSV-2
US20160053023A1 (en) 2013-04-09 2016-02-25 Annexon, Inc. Methods of treatment for neuromyelitis optica
CN105209047B (en) 2013-04-18 2020-08-18 免疫设计股份有限公司 GLA monotherapy for cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
AU2014287221C1 (en) 2013-07-09 2020-03-05 Annexon, Inc. Anti-complement factor C1q antibodies and uses thereof
CN106163551A (en) 2013-12-31 2016-11-23 传染性疾病研究院 Single bottle of bacterin preparation
US9891216B2 (en) 2014-04-02 2018-02-13 Chembio Diagnostic Systems, Inc. Immunoassay methods utilizing trapping conjugate
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
AU2015343029B2 (en) 2014-11-05 2021-07-29 Annexon, Inc. Humanized anti-complement factor C1q antibodies and uses thereof
AU2016361517C1 (en) 2015-11-24 2024-06-06 Annexon, Inc. Anti-complement factor C1q Fab fragments and uses thereof
JP7140684B2 (en) 2016-06-01 2022-09-21 アクセス ツー アドバンスト ヘルス インスティチュート Nano Alum Particles Containing Sizing Agent
CN109991405B (en) * 2017-12-29 2023-01-24 上海索昕生物科技有限公司 Immunoassay kit and application thereof
MX2021014363A (en) 2019-05-25 2022-02-21 Infectious Disease Res Inst Composition and method for spray drying an adjuvant vaccine emulsion.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138213A (en) * 1974-05-20 1979-02-06 Technicon Instruments Corporation Agglutination immunoassay of immune complex with RF or Clq
GB1508132A (en) * 1974-05-20 1978-04-19 Technicon Instr Analysis of biological fluids
GB1590524A (en) * 1976-11-24 1981-06-03 Nat Res Dev Assay of immune complexes
US4210622A (en) * 1977-09-07 1980-07-01 National Research Development Corporation Kit for assay of immune complexes
AU6786781A (en) * 1980-02-22 1981-09-11 Scripps Clinic & Research Foundation The solid phase anti-c3 assay for detection of immune complexes
AU8991582A (en) * 1981-09-18 1983-04-08 Georgetown University Monoclonal antibody detection system
KR880001097B1 (en) * 1982-08-12 1988-06-29 다이아몬드 샴락크 코오포레이션 Biospecific polymer
US4595654A (en) * 1983-11-07 1986-06-17 Immunomedics Inc. Method for detecting immune complexes in serum

Also Published As

Publication number Publication date
CA1247539A (en) 1988-12-28
ATE66531T1 (en) 1991-09-15
IT1177121B (en) 1987-08-26
EP0161306B1 (en) 1991-08-21
EP0161306A4 (en) 1987-04-14
DK309285A (en) 1985-07-05
JPH0731195B2 (en) 1995-04-10
IT8423468A1 (en) 1986-05-07
AU575362B2 (en) 1988-07-28
JPH06105699A (en) 1994-04-19
IL73437A (en) 1992-06-21
AU3615384A (en) 1985-06-03
WO1985002261A1 (en) 1985-05-23
IT8423468A0 (en) 1984-11-07
JPH0739440B2 (en) 1995-05-01
EP0161306A1 (en) 1985-11-21
NO852705L (en) 1985-08-21
US4595654A (en) 1986-06-17
DE3484957D1 (en) 1991-09-26
IL73437A0 (en) 1985-02-28
JPS61500315A (en) 1986-02-27

Similar Documents

Publication Publication Date Title
DK309285A (en) PROCEDURE FOR DETERMINING SERUM IMMUNIC COMPLEXS
DK158284D0 (en) MONOCLONAL ANTIBODIES DERIVED FROM CROSS-BONDED FIBRIN DERIVATIVES AND ANALYSIS METHOD FOR DETERMINING THESE DERIVATIVES
SE8102558L (en) IMMUNOLOGICAL DETERMINATION METHOD
EP0089008A3 (en) Method for the combined immunological determination of procollagen peptide (type iii) and procollagen peptide col 1 (type iii), and method for the production of anti-procollagen peptide col 1 (type iii) serum
ATE1614T1 (en) IMMUNOLOGICAL DETERMINATION PROCEDURE.
DK212986D0 (en) PROCEDURE FOR DETERMINING A SUBSTANCE IN A TEST
NO175657C (en) Method for performing an immunological determination of an antigen in a liquid sample as well as reagents for use therein.
SE7904386L (en) BIOLOGICAL TEST METHOD WITH USE OF SOLID PHASE
NO843591L (en) PROCEDURE FOR AA DETERMINING PIVKA-II CONTENTS IN BLOOD PLASMA AND METHOD FOR EXECUTING THIS
ES2033823T3 (en) TRIAL AS TO HUMAN BREAST CANCER.
ATE16219T1 (en) LATEX IMMUNOLOGICAL AGGLUTINATION PROCEDURE.
DK156926C (en) PROCEDURE FOR DETERMINING THE PRESENCE OF AN ANTIGEN OR ANTIBODY IN A TEST LIQUID BY MEASURING ERYTHROCYTE DIMENSION AND THE TEST PROCEDURE TO CARRY OUT THE PROCEDURE
DK327289A (en) DIAGNOSTIC METHODS AND SYSTEMS FOR QUANTIFYING APO AI
ATE9846T1 (en) RADIOIMMUNOASSAY FOR MIGRATION INHIBITION FACTOR.
EP0271810A3 (en) Immunological determination of free human protein s and c4bp-protein s complex
ATE114052T1 (en) IMMUNOASSAY TO DETERMINE THE BINDING SPECIFICITY OF A MONOCLONAL ANTIBODY.
ATE79475T1 (en) PROCEDURE FOR DETERMINING IMMUNOGLOBULIN APROTEASE.
DE3874741D1 (en) IMMUNASSAY PROCEDURE.
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
EP0315447A3 (en) Method of immunological measurement of human protein s and reagent and kit therefor
ATE41242T1 (en) PROCEDURE FOR DETERMINING AN IMMUNOLOGICALLY BINDABLE SUBSTANCE.
SE8705137D0 (en) DIAGNOSTIC METHOD FOR PRIMARY BILIARY CIRRHOSIS AND ANTIBODIES SUITABLE TO BE USED IN CERTAIN VERSIONS OF THE METHOD
KR850003169A (en) Measurement method and reagent of basic fetal protein
BR9105983A (en) MONOCLONAL ANTIBODIES THAT DIFFERENTIATE BETWEEN NATIVE AND MODIFIED SEQUENCE PROTEINS
ATE281471T1 (en) ANTIBODIES TEST KIT FOR DETERMINING AMYLIN

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment